ENSYSCE BIOSCIENCES
Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP) and Multi-Pill Abuse Resistance (MPAR™) platforms, the company is in the process of developing a new class of tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
ENSYSCE BIOSCIENCES
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ensysce.com
Total Employee:
11+
Status:
Active
Contact:
+1 858 263 4196
Email Addresses:
[email protected]
Total Funding:
101.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins
Similar Organizations
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-19 | Signature Therapeutics, Inc. | Signature Therapeutics, Inc. acquired by Ensysce Biosciences | N/A |
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Private Equity Round - Ensysce Biosciences
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Ensysce Biosciences
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Ensysce Biosciences
Texas Wide Open for Business
Texas Wide Open for Business investment in Venture Round - Ensysce Biosciences
Texas Wide Open for Business
Texas Wide Open for Business investment in Series A - Ensysce Biosciences
Key Employee Changes
Official Site Inspections
http://www.ensysce.com
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
